MiMedx Group, Inc. APIC, Share-based Payment Arrangement, Increase for Cost Recognition
MiMedx Group, Inc. (MDXG) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $903.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Shareholders' Equity
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-07-29
- MiMedx Group, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-06-30 was $903.00K, a 81.01% decline year-over-year.
- MiMedx Group, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-03-31 was -$1.69M, a 139.61% decline year-over-year.
- MiMedx Group, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-12-31 was $2.46M, a 47.52% decline year-over-year.
- MiMedx Group, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-09-30 was $4.92M, a 29.11% increase year-over-year.
- MiMedx Group, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2025 was $16.40M, a 3.17% decline from fiscal 2024.
- MiMedx Group, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2024 was $16.93M, a 1.43% decline from fiscal 2023.
- MiMedx Group, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2023 was $17.18M, a 35.62% increase from fiscal 2022.
- MiMedx Group, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2022 was $12.67M, a 14.17% decline from fiscal 2021.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $903.00K 10-Q · filed 2026-07-29 | -$793.00K 10-Q · filed 2026-07-29 | $1.68M derived: sum of 3 quarters · filed 2026-07-29 | $6.60M derived: sum of 4 quarters · filed 2026-07-29 | |
| 2026-03-31 | -$1.69M 10-Q · filed 2026-04-29 | $776.00K derived: sum of 2 quarters · filed 2026-04-29 | $5.70M derived: sum of 3 quarters · filed 2026-04-29 | $10.45M derived: sum of 4 quarters · filed 2026-07-29 | |
| 2025-12-31 | $2.46M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $7.38M derived: sum of 2 quarters · filed 2026-02-25 | $12.14M derived: sum of 3 quarters · filed 2026-07-29 | $16.40M 10-K · filed 2026-02-25 | |
| 2025-09-30 | $4.92M 10-Q · filed 2025-10-29 | $9.68M derived: sum of 2 quarters · filed 2026-07-29 | $13.93M 10-Q · filed 2025-10-29 | $18.63M derived: sum of 4 quarters · filed 2026-07-29 | |
| 2025-06-30 | $4.76M 10-Q · filed 2026-07-29 | $9.01M 10-Q · filed 2026-07-29 | $13.71M derived: sum of 3 quarters · filed 2026-07-29 | $17.52M derived: sum of 4 quarters · filed 2026-07-29 | |
| 2025-03-31 | $4.26M 10-Q · filed 2026-04-29 | $8.95M derived: sum of 2 quarters · filed 2026-04-29 | $12.76M derived: sum of 3 quarters · filed 2026-04-29 | $16.85M derived: sum of 4 quarters · filed 2026-04-29 | |
| 2024-12-31 | $4.69M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $8.50M derived: sum of 2 quarters · filed 2026-02-25 | $12.59M derived: sum of 3 quarters · filed 2026-02-25 | $16.93M 10-K · filed 2026-02-25 | |
| 2024-09-30 | $3.81M 10-Q · filed 2025-10-29 | $7.90M derived: sum of 2 quarters · filed 2025-10-29 | $12.24M 10-Q · filed 2025-10-29 | $16.63M derived: sum of 4 quarters · filed 2026-02-25 | |
| 2024-06-30 | $4.09M 10-Q · filed 2025-07-30 | $8.43M 10-Q · filed 2025-07-30 | $12.82M derived: sum of 3 quarters · filed 2026-02-25 | $17.20M derived: sum of 4 quarters · filed 2026-02-25 | |
| 2024-03-31 | $4.34M 10-Q · filed 2025-04-30 | $8.72M derived: sum of 2 quarters · filed 2026-02-25 | $13.11M derived: sum of 3 quarters · filed 2026-02-25 | $17.17M derived: sum of 4 quarters · filed 2026-02-25 | |
| 2023-12-31 | $4.38M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $8.77M derived: sum of 2 quarters · filed 2026-02-25 | $12.83M derived: sum of 3 quarters · filed 2026-02-25 | $17.18M 10-K · filed 2026-02-25 | |
| 2023-09-30 | $4.39M 10-Q · filed 2024-10-30 | $8.45M derived: sum of 2 quarters · filed 2024-10-30 | $12.79M 10-Q · filed 2024-10-30 | $14.66M derived: sum of 4 quarters · filed 2025-02-26 | |
| 2023-06-30 | $4.06M 10-Q · filed 2024-07-31 | $8.40M 10-Q · filed 2024-07-31 | $10.27M derived: sum of 3 quarters · filed 2025-02-26 | $12.64M derived: sum of 4 quarters · filed 2025-02-26 | |
| 2023-03-31 | $4.34M 10-Q · filed 2024-04-30 | $6.21M derived: sum of 2 quarters · filed 2025-02-26 | $8.59M derived: sum of 3 quarters · filed 2025-02-26 | $13.01M derived: sum of 4 quarters · filed 2025-02-26 | |
| 2022-12-31 | $1.87M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $4.24M derived: sum of 2 quarters · filed 2025-02-26 | $8.67M derived: sum of 3 quarters · filed 2025-02-26 | $12.67M 10-K · filed 2025-02-26 | |
| 2022-09-30 | $2.37M 10-Q · filed 2023-10-30 | $6.80M derived: sum of 2 quarters · filed 2023-10-30 | $10.80M 10-Q · filed 2023-10-30 | $14.44M derived: sum of 4 quarters · filed 2024-02-28 | |
| 2022-06-30 | $4.43M 10-Q · filed 2023-08-01 | $8.43M 10-Q · filed 2023-08-01 | $12.07M derived: sum of 3 quarters · filed 2024-02-28 | $15.88M derived: sum of 4 quarters · filed 2024-02-28 | |
| 2022-03-31 | $4.00M 10-Q · filed 2023-05-02 | $7.64M derived: sum of 2 quarters · filed 2024-02-28 | $11.45M derived: sum of 3 quarters · filed 2024-02-28 | $15.51M derived: sum of 4 quarters · filed 2024-02-28 | |
| 2021-12-31 | $3.64M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $7.45M derived: sum of 2 quarters · filed 2024-02-28 | $11.51M derived: sum of 3 quarters · filed 2024-02-28 | $14.76M 10-K · filed 2024-02-28 | |
| 2021-09-30 | $3.81M 10-Q · filed 2022-11-02 | $7.87M derived: sum of 2 quarters · filed 2022-11-02 | $11.12M 10-Q · filed 2022-11-02 | ||
| 2021-06-30 | $4.06M 10-Q · filed 2022-08-02 | $7.30M 10-Q · filed 2022-08-02 | |||
| 2021-03-31 | $3.24M 10-Q · filed 2022-05-03 | ||||
| 2020-12-31 | $15.73M 10-K · filed 2023-02-28 | ||||
| 2014-09-30 | $3.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | $5.79M derived: sum of 2 quarters · filed 2014-11-10 | $8.16M 10-Q · filed 2014-11-10 | $10.01M derived: sum of 4 quarters · filed 2014-11-10 | |
| 2014-06-30 | $2.77M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | $5.14M 10-Q · filed 2014-08-11 | $6.99M derived: sum of 3 quarters · filed 2014-08-11 | $8.66M derived: sum of 4 quarters · filed 2014-08-11 | |
| 2014-03-31 | $2.37M 10-Q · filed 2014-05-12 | $4.23M derived: sum of 2 quarters · filed 2014-05-12 | $5.89M derived: sum of 3 quarters · filed 2014-05-12 | $7.40M derived: sum of 4 quarters · filed 2014-05-12 | |
| 2013-12-31 | $1.85M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-04 | $3.52M derived: sum of 2 quarters · filed 2014-03-04 | $5.02M derived: sum of 3 quarters · filed 2014-03-04 | $6.01M 10-K · filed 2014-03-04 | |
| 2013-09-30 | $1.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08 | $3.17M derived: sum of 2 quarters · filed 2013-11-08 | $4.16M 10-Q · filed 2013-11-08 | $5.26M derived: sum of 4 quarters · filed 2014-03-04 | |
| 2013-06-30 | $1.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | $2.49M 10-Q · filed 2013-08-08 | $3.59M derived: sum of 3 quarters · filed 2014-03-04 | $4.15M derived: sum of 4 quarters · filed 2014-03-04 | |
| 2013-03-31 | $984.79K 10-Q · filed 2013-05-10 | $2.09M derived: sum of 2 quarters · filed 2014-03-04 | $2.65M derived: sum of 3 quarters · filed 2014-03-04 | $3.12M derived: sum of 4 quarters · filed 2014-03-04 | |
| 2012-12-31 | $1.11M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-04 | $1.66M derived: sum of 2 quarters · filed 2014-03-04 | $2.14M derived: sum of 3 quarters · filed 2014-03-04 | $2.54M 10-K · filed 2014-03-04 | $2.08M 10-K · filed 2013-03-15 |
| 2012-09-30 | $554.14K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-13 | $1.03M derived: sum of 2 quarters · filed 2012-11-13 | $1.43M 10-Q · filed 2012-11-13 | $2.06M derived: sum of 4 quarters · filed 2014-03-04 | |
| 2012-06-30 | $478.44K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-14 | $878.49K 10-Q · filed 2012-08-14 | $1.51M derived: sum of 3 quarters · filed 2014-03-04 | $1.73M derived: sum of 4 quarters · filed 2014-03-04 | |
| 2012-03-31 | $400.05K 10-Q · filed 2012-05-14 | $1.03M derived: sum of 2 quarters · filed 2014-03-04 | $1.25M derived: sum of 3 quarters · filed 2014-03-04 | ||
| 2011-12-31 | $626.82K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-04 | $849.61K derived: sum of 2 quarters · filed 2014-03-04 | $1.66M 10-K · filed 2014-03-04 | $1.31M 10-K · filed 2012-03-29 | |
| 2011-09-30 | $222.79K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | $1.03M 10-Q · filed 2011-11-14 | |||
| 2011-06-30 | $809.47K 10-Q · filed 2011-08-04 | ||||
| 2010-12-31 | $996.31K 10-K · filed 2012-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B |